Quorix

Private research on macroeconomic trends, emerging technologies, and quantitative theses.

Not investment advice.

[Quorix @QuorixResearch]

East Asia’s Robotaxi Race Is Moving Beyond Small Trials China is already running millions of driverless rides.

Japan, South Korea and Taiwan are shifting from pilots toward paid service and manufacturing. The next test is cost and operations, not just software.

Quorix Insight: https://t.co/5Uv22g3lpc

[Quorix @QuorixResearch]

The Dawn of Quantum Technology in Hong Kong Banking

Quantum computing may improve risk modelling and fraud detection but it also threatens the cryptography banks rely on.

Quorix Insight: https://t.co/znyUl45sSH

[Quorix @QuorixResearch]

The "Pill Penalty": Is It Priced In? Markets already seem to treat the IRA’s 9-year vs 13-year negotiation gap as real.

High-exposure small-molecule pharma stocks underperformed around every major Medicare pricing milestone.

Quorix Insight: https://t.co/ouicGxwEfA

[Quorix @QuorixResearch]

China Never Exited Deflation

Headline producer prices rose on oil and commodities, but prices of the finished consumer goods China exports are still falling. Factories are swallowing higher costs and shipping the deflation abroad.

Quorix Insight: https://t.co/kX3SX2Gsx6

[Quorix @QuorixResearch]

Kimi vs Claude: Similar Intelligence, Different Paths Kimi K3 and Claude Fable 5 are nearly tied on intelligence but take opposite paths.

Claude prioritizes reliable enterprise work; Kimi bets on long context, open weights, parallel agents and lower prices.

https://t.co/hbB0nAirzy

[Quorix @QuorixResearch]

Artificial Intelligence Is Reshaping the Global Labor Market

AI is boosting productivity across knowledge work while shifting demand toward complementary skills and fewer entry-level hires. The real story is human-AI collaboration, not mass unemployment.

Quorix Insight: https://t.co/m5AZeRmoAa

[Quorix @QuorixResearch]

The Idiosyncratic Bet

AI-native drug discovery isn’t a new asset class, it’s a wager on shrinking the one biotech risk that was never diversifiable: the probability a molecule works.

Quorix Insight: https://t.co/wdASln1D3H

[Quorix @QuorixResearch]

Real-Time Payments: From Competitive Edge to Operational Imperative Instant settlement is now basic infrastructure.

PayNow surpassed 1.2B transactions and FedNow surged 459% YoY.

New Insight: https://t.co/uElMAC6awh

[Quorix @QuorixResearch]

The Rise of Private Credit Is Reshaping Global Financial Markets

From niche alternative to a $2T+ parallel banking system. Banks are retreating, private lenders are stepping in with flexible capital.

Our new Insight: https://t.co/FG5C8WV3xR

[Quorix @QuorixResearch]

Programmable probiotics are becoming living medicines that sense disease, produce therapeutics & alter metabolism moving far beyond the gut.

Quorix Insight: https://t.co/cR8kAmR6sM

[Quorix @QuorixResearch]

Who actually buys the trillion-dollar IPOs? Follow the Gulf.

Gulf sovereign wealth funds backed by oil are the anchors for the ~$200B raises from SpaceX, OpenAI & Anthropic, far more than 2025’s total US IPOs.

Full insight: https://t.co/hF27bOHixZ

[Quorix @QuorixResearch]

The @RobinhoodCrypto Chain is an AI-native Ethereum L2 built for tokenized real-world assets and onchain finance.

It leverages Robinhood’s ~28 million users for distribution, delivered 100M+ TVL in its first week, and features strong RWA composability with Chainlink and DeFi integrations.

Full analysis: https://t.co/usHvYZTg2m

[Quorix @QuorixResearch]

The GLP-1 supplement opportunity lies not in products positioned as Ozempic alternatives, but in the ecosystem of on-drug support and post-discontinuation maintenance solutions for this growing patient population.

Insight: https://t.co/om92Fxrxpj

[Quorix @QuorixResearch]

Quorix releases its first quantitative thesis: Valuation Models for Physical AI.

We developed a data-driven framework showing that technical model performance and real-world deployments are now the strongest drivers of valuations in the Physical AI sector ahead of stage or investor quality. A practical guide for investors cutting through the hype.

Full thesis → https://t.co/rMyW2Kxztv

[Quorix @QuorixResearch]

Agentic AI may first win in enterprises by fixing coordination challenges across teams, processes, and systems rather than through isolated task automation.

Read the insight:
https://t.co/seeADrC9J1

#AgenticAI #EnterpriseAI

[Quorix @QuorixResearch]

Why CPUs Are Suddenly Back in Demand

Our latest analysis examines why CPUs are regaining prominence amid shifting AI workloads and infrastructure constraints.

Read the full report: https://t.co/i8LwWCHGm9

[Quorix @QuorixResearch]

Interest rate changes are pushing fintech companies to pursue banking licenses.

Read our latest insight on the drivers and implications: https://t.co/Fif6TgC1dQ

[Quorix @QuorixResearch]

Precision fermentation is enabling the scalable production of Human Milk Oligosaccharides (HMOs), creating a significant new opportunity in the dietary supplements market.

Originally established in infant formula, these bioactive compounds found in human milk are now expanding into adult applications, with growing interest in gut microbiome and immune health benefits.

Read the full Quorix insight here:
https://t.co/KklPbN6hAQ

[Quorix @QuorixResearch]

Robotics is approaching its next critical test as systems move from controlled environments into complex, real-world settings.

A new Quorix insight examines the key challenges that will determine the next phase of progress.

Read the full analysis:
https://t.co/PH0akCzAxc

[Quorix @QuorixResearch]

Will $SPCX crash after the @SpaceX IPO?

Short-term volatility is likely, but a full crash is far from certain.

Professional breakdown here:
https://t.co/35jhUqXq4d